All the latest news on the marijuana space delivered directly to your inbox.
TheSeedInvestor
Read our Investor Dashboard on OTC:ABCCF TSX.v ABCN
There will be a sudden wave of "Marijuana Millionaires" in 2017 - will you be one?

 
13x13x1 READ MORE
UNDERSTANDING INMED: Drug Development IP to Pipeline.
LEARN MORE
600x300
Emblem Announces $50 Million Bought Deal
Emblem Corp. (TSX VENTURE:EMC)(TSX VENTURE:EMC.WT) is pleased to announce that it has entered into a letter of engagement with Eight Capital pursuant to which Eight Capital has agreed to purchase 12,195,123 units and 25,000 convertible unsecured debentures of the Company, on a "bought deal" basis
13x13x1 READ MORE
600x300
GrowGeneration Raises $9.0 Million in Growth Capital
Company Increases 2018 Revenue Guidance To Over $30 Million
13x13x1 READ MORE
600x300
Will New York Finally Consider Legalizing Cannabis This Week?
A panel of lawmakers will now hear testimony from some of the state's most experienced advocates for reform. On Thursday morning, the New York State Assembly Standing Committees on Codes, Health, and Alcohol and Drug Abuse will convene a public hearing to discuss the Marijuana Regulation and Taxation Act (MRTA), aimed to legalize the use, distribution, and production of cannabis for adults aged 21 and over.
13x13x1 READ MORE
Please see full disclaimers on the TheSeedInvestor.com website applicable to all content provided by TSI, wherever published or re-published: http://theseedinvestor.com/about/disclaimerDisclaimer.

This news release/advertorial is a commercial advertisement and is for general information purposes only. We are engaged in the business of marketing and advertising companies for monetary compensation. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. It is possible that a viewer’s entire investment may be lost or impaired due to the speculative nature of the companies profiled. Remember, never invest in any security of a company profiled or discussed on this website unless you can afford to lose your entire investment. Also, investing in small-cap and micro-cap securities is highly speculative and carries an extremely high degree of risk. This website makes no recommendation that the securities of the companies profiled or discussed on this website should be purchased, sold or held by viewers that learn of the profiled companies through our website. Compensation: A thirty-six-thousand-dollar investor relations budget is being managed by The Seed Investor. Any funds leftover after expenses for research, overhead, advertising and public relations related to InMed Pharmaceuticals Inc. (ticker symbol (CSE: IN; OTCQB: IMLFF) will be considered profit. The Seed Investor and/or entities related to The Seed Investor hold shares in (CSE: IN; OTCQB: IMLFF) and intend to sell those shares. Please review all investment decisions with a licensed inv­estment advisor. 
 
32x32x1   32x32x2  
TheSeedInvestor.com
9375 E Shea Blvd Ste 100
Scottsdale 85260
info@theseedinvestor.com
 
©2019, All Rights Reserved  |  Unsubscribe   |   View this in Browser

To keep receiving emails from us, please add us to your address book.